Filing Flows › Agios Pharmaceuticals (AGIO) › Recalls, complaints & regulation
Agios Pharmaceuticals (AGIO): clinical trials
Agios Pharmaceuticals (AGIO) beyond its filings: 16 active clinical trials.
Agios Pharmaceuticals' latest quarter
Agios Pharmaceuticals, Q3 2026: revenue $55.4M (+330% year over year), operating margin -139.3%, net loss $65.0M, operating cash flow −$59.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Agios Pharmaceuticals have?
16 active studies on ClinicalTrials.gov, 9 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.